FDA approves HPV Vaccine for adults over 26 and up to 45 in an effort to reduce HPV-caused cancers
Events, Seminars, & Publications
22. 10. 2018
The US Food and Drug Administration expanded its approval of the HPV vaccine to include women and men up to 45-year-old, in an effort to protect more people from several types of cancer -including cer...[Read more]
